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Recently, it has been reported that longer expansions of the
polyalanine tract of the ARX gene could cause an early infantile
encephalopathy with suppression burst pattern and that the
length of this repeat region could be related to the severity of
the electroclinical picture. We describe the history of two male
individuals, born frommonozygotic twin sisters, with Ohtahara
syndrome (OS) that evolved intoWest syndrome phenotype and
epileptic encephalopathy. In both children, we have found a
previously unreported missensemutation in exon 5 ofARX gene
(c.1604T>A) resulting in the substitution of a leucine with a
glutamine in the aminoacid sequence. The two mothers and the
maternal grandmother carry the same mutation which segre-
gates with the disease phenotype in the family. This study
confirms thatARX is involved in the pathogenesis of cryptogenic
early onset epileptic encephalopathy, such as OS, and suggests
that the severity of the electroclinical picture is likely to not
exclusively correlate with the extent of expansions of the poly-
alanine tracts, but rather with the functional effect of different
pathogenetic mutations.  2010 Wiley-Liss, Inc.
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INTRODUCTION
Mutations of the Aristaless-related homeobox (ARX) gene (OMIM
*300382) cause a variety of neurological disorders including infan-
tile spasms with or without dystonia or other movement disorders,
with or without cerebral malformations [Kato et al., 2004; Guerrini
et al., 2007; Poirier et al., 2008]. The genotype–phenotype correla-
tion seems to indicate that malformation phenotypes are caused by
protein truncation mutations and missense mutations in the
homeobox, whereas nonmalformation phenotypes are associated
with missense mutations outside the homeobox and with poly-
alanine tract expansion [Kato et al., 2007].
Expansions of the first polyalanine tract of the ARX gene are
associated with X-linked infantile spasm syndrome and epileptic
dyskinetic encephalopathy [Stromme et al., 2002; Turner et al.,
2002; Kato and Dobyns, 2005; Guerrini et al., 2007]. Longer
expansions of the same polyalanine tract have been recently re-
ported as a cause of early infantile epileptic encephalopathy with
suppression burst pattern (Ohtahara syndrome; OS) without brain
malformations and a possible relationship between the length of
this repeat region and the severity of the epileptic phenotype has
been suggested [Kato et al., 2003, 2007].
To further support the possible causative relationship between
ARXgenemutations andOS,we report two relatedmale individuals
with OS that evolved into West syndrome phenotype and subse-
quently into an epileptic encephalopathy with polymorphic and
refractory seizures, who carry a previously unreported missense
mutations in exon five of ARX gene.
CLINICAL REPORTS
The two boys we report on were born to two monozygotic twin
sisters and both had a neonatal-onset encephalopathy. A maternal
uncle, who died at 2 years of age during a prolonged status
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epilepticus was reported as affected by neonatal-onset spasms and
successive refractory focal seizures (Fig. 1).
Patient 1
Patient 1 was the first child of healthy unrelated parents, born at
term, after an uneventful pregnancy and vacuum-assisted delivery.
At birth weight was 2,380 g (<3rd centile), length was 47 cm (3rd
centile), and head circumference was 31 cm (2nd centile). At age 20
days, especially at drowsiness, he presented clusters of spasms
associated with erratic myoclonic jerks.
The EEG disclosed a suppression burst pattern compatible with
OS (Fig. 2). Adrenocorticotropic hormone and vigabatrin were not
effective. After the introduction of valproate, spasm frequency
decreased but the EEG became hypsarrhythmic.
Thegrowthparameters remained lowduringhis development: at
6 months head circumference was 41 cm (2nd centile), weight
6,500 g (3rd centile), and length 63 cm (3rd centile); at 12 months
head circumference was 42 cm (<2nd centile), weight 9,300 g
(10th centile), and length 72 cm (3rd centile) and now (22 months
of age) he showed microcephaly (head circumference 42 cm,
<2nd centile) andgrowthdeficiency (weight 10,000 g,<3rd centile,
length 85 cm, 25th centile) without dysmorphic features, intellec-
tual impairment, hypotonic tetraparesis with pyramidal signs, and
requires gavage feeding. Physical examination did not reveal any
genital anomaly and nowpenile stretched length is 3.5 cm (10–50th
centile). Daily isolated spasms and focal seizures persist despite
the therapy; the EEG is characterized by multifocal paroxysms.
Metabolic tests [very long chain fatty acids (VLCFA), plasma
and urinary aminoacids, carnitine, and acilcarnitine] showed nor-
mal results. Brain MRI performed at 6 months of age was normal,
while at 22 months it showed diffuse brain atrophy. Standard
karyotype and analysis of telomeric rearrangements were both
normal.
FIG. 1. Family pedigree. Pedigree shows four affected probands on three different generations: in (a) a wild-type sequence is reported; in (b) genomic
sequence carrying the mutation and cDNA, below, sequence are shown; in (c) sequence of heterozygous mother is evidenced. [Color figure can be
viewed in the online issue, which is available at www.wileyonlinelibrary.com]
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Patient 2
Patient 2 was the second child of nonconsanguineous parents. The
father had benign childhood epilepsy. Pregnancy, delivery, weight
(3,200 g), length (51 cm), and head circumference (33 cm) at birth
were normal. Focal seizures, characterized by staring followed by
right-side jerks and brief generalized clonic attacks, occurred at
6 days of life. EEG showed a suppression-burst pattern that was
compatible with OS (Fig. 3). Vitamin B6, phenobarbital, and
midazolam were used without success. At age 2 months, he pre-
sented with polymorphic focal motor seizures associated with
spasms in clusters evolving into epileptic encephalopathy resistant
to vigabatrin, phenytoin, adrenocorticotropic hormone. The EEG
became hypsarrhythmic. Other treatments (lamotrigine, carba-
mazepine, clobazam, and valproate) did not change seizurefre-
quency. Postnatal development was within normal ranges since the
age of 22months, when he showed progressive deceleration of head
circumference (46.5 cm, 50th–2nd centile). At the age of 2 years, he
had microcephaly (head circumference 46.5 cm,<2nd centile;
weight 10,400 g, 10th centile; length 87 cm, 50th centile) without
dysmorphic features, intellectual impairment, and spastic tetrapa-
resis requiring gavage feeding.Nogenital anomalieswere foundand
penile stretched length was 4 cm (50th centile) at the age of 2 years.
Results of several investigations (blood lactate and ammonium,
plasma aminoacids, VLCFA, serum sialotransferrin isofocusing,
purines and pyrimidines, sulfi-test, serum copper and ceruloplas-
min, CSF analysis and dosage of neurotransmitters, urinary excre-
tion of organic acids and aminoacids) were negative. Brain MRI at
age 6dayswasnormal, and consecutiveMRI at age 2 years revealed a
slight diffuse brain atrophy. Standard karyotype was normal.
Molecular analysis
Regular informed consent for genetic testing was obtained from the
parents of the two affected boys. Genomic DNA was extracted from
peripheral blood leukocytes (PBL) with standardmethods.Mutation
analysis of the ARX gene was performed by PCR amplification and
direct sequencing of fragments representing all the coding exons and
intron–exon boundaries, with primers and conditions modified by
Kato et al. [2004]. Direct sequencing of the amplification products
was performed with the use of the BigDye Terminator v3.1 Cycle
Sequencing Kit (PE Applied Biosystems, Foster City, CA) on an ABI
3100 automated DNA sequencer (Applied Biosystems). The sequen-
ces obtained were compared with the reference ARX sequence
(GenBank accession number:NM_139058) byBLAST analysis. Total
RNA was extracted from fresh peripheral blood using the Trizol
procedure (Life Technologies, Grand Island, NY) and cDNA was
obtained using the superscript first-strand system for RT-PCR, with
the primers being selected by Primer Express software. Primers
amplifying a product from exon 4 to exon 5, fw: 5’-CCAGCTTT-
CATCAGCCCGGC-3’ and rev: 5’-GTGCTGGTGCCCGGCAGG-3’
were designed for the missense mutation.
RESULTS
The mutation scanning performed allowed us to detect, in both
individuals, the presence of a single base substitution at nucleotide
1604 of the ARX gene coding sequence (c.1604T>A: Ref. Seq.
NM_139058), resulting in the substitution of the leucine residue
at position 535 of the aminoacid sequence with a glutamine
(p.Leu535Gln). The substitution has not been found in 150 X
chromosomes from the control population. The same mutation
was present in the DNA of the two mothers, and maternal grand-
mother, while it was absent in the two unaffected maternal uncles.
Moreover, linkage analysis (data not shown) with a panel of
microsatellites, spanning the whole X chromosome excluded the
disease causing involvement of other X chromosome loci. RT-PCR
analysis evidenced the transcription of the mutant allele.
DISCUSSION
Both children presented with specific electroclinical features sug-
gestive of OS subsequently evolving into a drug-resistant epileptic
FIG. 2. EEG patient 1. At 1 month of age the child presents a suppression-burst pattern that is compatible with OS.
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encephalopathy with spasms. The X-linked inheritance, suggested
by the family history, is confirmed by the molecular results.
Besides both children show a clinical phenotype characterized by
microcephaly without dysmorphic features and absence of genital
anomalies, although patient one presented growth deficiency from
birth, while Patient 2 showed normal auxological measures at birth
and developed progressive microcephaly in the second year of life.
In both cases diffuse brain atrophy onMRI at 2 years of age could
be related to the persistence of severe epileptic encephalopathy.
The electroclinical features of our subjects, except for the absence
of genitalia malformations, are similar to those reported by Kato
et al. [2007]. Recently, a novel ARX gene mutation in male infant
without genital anomalies, presenting with OS associated with a
rapidly progressive and severe neurodegeneration with cortical
atrophy, has been described [Absoud et al., 2010].
This confirms the possible causative relationship between ARX
gene mutations and OS. The molecular analysis of the ARX gene
revealed a missense mutation (c.1604T>A) on the DNA of both
affected boys, of their mothers and grand mother. This previously
unreportedmutation, not found inmore than 100X chromosomes
of the general population, is to be considered pathogenic. In fact it
leads to a variation of the chemical characteristics of the aminoacid
sequence by substituting the nonpolar hydrophobic leucine residue
with a polar hydrophilic glutamine in the functionally relevant
Aristaless domain (p.Leu535Gln) of the gene.
To further confirm the disease-causing nature of the detected
variant, a multi-sequence alignment analysis was performed that
showed a strong phylogenetic conservation of the specific leucine
residue. The translation of the aberrant allele, as demonstrated by
the cDNAanalysis, excluded the occurrence of a nonsensemediated
RNA decay suggesting that the presence of an aberrant protein,
rather than its absence, is responsible for the disease. The absence of
the mutation in the unaffected uncles further supports the segre-
gation of the molecular defect with the disease.
Differently from sporadic OS cases [Kato et al., 2007; Absoud
et al., 2010], the novel mutation of the ARX gene we describe is
found to segregate in a family, and consists in a missense mutation
rather than in a longer expansion of the first polyalanine tract of the
gene.
The similar clinical phenotypes, characterized by microcephaly
without dysmorphic features and absence of genital anomalies, and
electroclinical picture, suggestive of OS, presented in the patients
we report on are important to better define the phenotype related to
this novel ARX gene mutation and to confirm the differentiation
between a malformative and nonmalformative group, related to
missense mutations outside the homeobox of the gene.
This report demonstrates the involvement of ARX gene muta-
tions other than longer polyalanine tract expansions, in the patho-
genesis of cryptogenic epileptic encephalopathy with very early
onset, such as OS. Our data suggests that the severity of the
electroclinical picture (OS vs. West syndrome) in patients with
ARX mutations does not simply, or exclusively, correlate with the
extent of expansions of the polyalanine tracts, but rather with the
functional effect of different pathogenetic mutations.
Furthermore, while supporting the causative relationship be-
tween ARX mutations and OS, our data strongly suggests the
opportunity for searching for ARX mutations in patients with
sporadic or familial OS.
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